↓ Skip to main content

Dove Medical Press

Article Metrics

Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

news
1 news outlet
twitter
2 tweeters
video
1 video uploader

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
40 Mendeley
Title
<p>Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date</p>
Published in
Therapeutics and Clinical Risk Management, January 2020
DOI 10.2147/tcrm.s210648
Pubmed ID
Authors

Jean Kim, Robert Naclerio

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 18%
Other 6 15%
Student > Doctoral Student 4 10%
Researcher 3 8%
Student > Ph. D. Student 3 8%
Other 8 20%
Unknown 9 23%
Readers by discipline Count As %
Medicine and Dentistry 19 48%
Biochemistry, Genetics and Molecular Biology 3 8%
Nursing and Health Professions 1 3%
Business, Management and Accounting 1 3%
Immunology and Microbiology 1 3%
Other 3 8%
Unknown 12 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2020.
All research outputs
#2,071,247
of 18,197,021 outputs
Outputs from Therapeutics and Clinical Risk Management
#86
of 1,128 outputs
Outputs of similar age
#53,822
of 342,661 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 3 outputs
Altmetric has tracked 18,197,021 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,128 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,661 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them